Zanidatamab
Zymeworks,Jazz
['zanida', 'zanidatamab', 'zymeworks', 'jazz']
jazz #pharmaceuticals and zymeworks announce exciting positive results from their pivotal phase 2b trial presented at asco 2023, showcasing the efficacy of zanidatamab in her2-amplified biliary tract cancers. learn more at 
By discovering the latest data on pharmaceutical #Clinical #Patent #News #indication #Pipeline to empower IP and R&D teams make more strategic decisions.